Skip to main content
SpringerLink
Log in

‘Excellent risk-benefit ratio’ with cisapride treatment

  • Newsletter Article
  • Published:
Inpharma Weekly

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

‘Excellent risk-benefit ratio’ with cisapride treatment. Inpharma Wkly. 994, 21 (1995). https://doi.org/10.2165/00128413-199509940-00044

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-199509940-00044

Keywords

Search

Navigation